UAE—Healthpoint, a member of the M42 group in the United Arab Emirates, has expanded its plastic and reconstructive surgery services to address complex chronic conditions such as lipedema and lymphedema.
These disorders involve abnormal fat or fluid accumulation, leading to persistent and often painful swelling.
Healthpoint’s enhanced services integrate advanced diagnostics with innovative treatments, utilizing artificial intelligence (AI) and cutting-edge technology to provide personalized patient care.
Lymphedema occurs when the lymphatic system is compromised, preventing proper drainage of lymph fluid.
This condition can be classified as primary, which is inherited genetically, or secondary, arising from factors such as lymph node removal, radiation therapy, injuries, or severe obesity.
Lymphedema is particularly common among breast cancer patients who have undergone procedures involving lymph node removal or radiation, with studies indicating that about 20% of these patients are at risk of developing lymphedema following surgery.
On the other hand, lipedema is characterized by abnormal fat distribution, primarily in the lower body, and is associated with genetic factors, hormonal imbalances, or obesity.
This condition predominantly affects women, with estimates from the National Institutes of Health (NIH) suggesting that nearly 11% of adult women worldwide suffer from lipedema.
At Healthpoint, the medical team evaluates lymphedema by assessing the extent of lymphatic fluid retention and tissue damage, identifying blockages within the lymphatic system to create tailored treatment plans.
These plans may include non-surgical conservative approaches or surgical interventions that reroute lymphatic fluid by connecting lymph vessels to veins, effectively bypassing obstructions or re-implanting lymph nodes.
In severe cases of lymphedema, specialized liposuction techniques are used to remove excess tissue without harming the remaining lymphatic vessels.
Recognizing the severity of one’s condition is crucial for effective management and preventing disease progression.
Dr. Nahla Al Mansoori, Head of the Plastic and Reconstructive Surgery Department at Healthpoint, emphasized that the expansion of services reflects their commitment to patient-centered care.
She noted that these new offerings not only address specific medical conditions but also align with M42’s goal to transform healthcare through advanced AI-driven solutions.
Dr. Al Mansoori further stated that enhancing their services highlights Healthpoint’s dedication to improving the lives of individuals affected by these challenging conditions.
Through personalized care plans and the latest medical advancements, Healthpoint aims to elevate the quality of life for those dealing with lipedema and lymphedema.
Sign up HERE to receive our email newsletters with the latest news and insights from Africa and beyond. Also, follow us on our WhatsApp channel for updates.
Be the first to leave a comment